DELCATH SYSTEMS, INC. Logo

DELCATH SYSTEMS, INC.

Interventional oncology company treating liver cancers with targeted chemotherapy.

DCTH | US

Overview

Corporate Details

ISIN(s):
US24661P8077
LEI:
Country:
United States of America
Address:
566 QUEENSBURY AVENUE, 12804 QUEENSBURY

Description

Delcath Systems, Inc. is a commercial-stage interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company develops and commercializes proprietary products for percutaneous hepatic perfusion (PHP), a minimally-invasive procedure designed to administer high-dose chemotherapy directly to the liver while controlling systemic exposure. Its flagship product in the United States is the HEPZATO KIT™ (melphalan/hepatic delivery system), an FDA-approved drug/device combination product for treating adult patients with metastatic uveal melanoma. In Europe, the company markets the CHEMOSAT® Hepatic Delivery System, a medical device for the same procedure.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2016-02-10 22:25
PROSPECTUS SUPPLEMENT NO. 8
English 11.7 KB
2016-02-10 22:20
FORM 8-K
English 10.2 KB
2016-01-22 22:24
FORM 8-K
English 13.4 MB
2016-01-19 23:35
424B5
English 27.9 KB
2015-11-25 22:08
PROSPECTUS SUPPLEMENT NO. 7
English 13.5 KB
2015-11-25 22:05
FORM 8-K
English 12.9 KB
2015-11-12 22:14
PROSPECTUS SUPPLEMENT NO. 6
English 101.4 KB
2015-11-10 22:05
10-Q
English 710.8 KB
2015-10-21 06:15 English 5.1 KB
2015-10-16 20:02 English 6.6 KB
2015-10-15 23:04
PROSPECTUS SUPPLEMENT NO. 5
English 10.7 KB
2015-10-15 23:00
FORM 8-K
English 9.1 KB
2015-10-15 21:26 English 224.7 KB
2015-10-09 22:52
FORM 8-K
English 1.1 MB
2015-10-07 23:16
FORM S-3
English 150.9 KB

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cessatech A/S Logo
A biotech company developing medicines for children's acute pain management.
Denmark
CESSA
CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.